Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
Predictors of delayed sputum culture conversion in tuberculosis patients Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005
When do we extend the treatment of tuberculosis (TB) more than 6 months? Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Reducing loss to follow-up during treatment for drug-resistant tuberculosis Source: Eur Respir J, 53 (1) 1802268; 10.1183/13993003.02268-2018 Year: 2019
Multidrug-resistant tuberculosis: treatment outcome after 18 months of invidualised therapy Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001
Risk factors for late smear and culture conversion in tuberculosis patients Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Factors affecting sputum conversion time in patients with smear positive tuberculosis Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
The relevance of smear exam at two month of re-treatment for further evolution of the relapsed TB cases Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
The significance of smear result at two months in pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002
Treatment outcomes of smear positive pulmonary tuberculosis cases Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Reevaluation of treatment outcome of relapse and defaulter pulmonary tuberculosis cases Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011
Risk factors and clinical outcomes of delayed smear conversion in smear positive pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Sputum smear negative pulmonary tuberculosis (PTB) – when should the treatment be started? Source: Eur Respir J 2006; 28: Suppl. 50, 505s Year: 2006
The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006